Validation of a commercially available indirect assay for SARS-CoV-2 neutralising antibodies using a pseudotyped virus assay (2021)

First Author: Murray M

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.21203/rs.3.rs-197836/v1

Publication URI: http://dx.doi.org/10.21203/rs.3.rs-197836/v1

Type: Preprint